GST-HG131
- Generic Name
- GST-HG131
A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
Phase 2
Recruiting
- Conditions
- Chronic Hepatitis B
- Interventions
- Drug: Placebo to match GST-HG131
- First Posted Date
- 2024-02-16
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- Fujian Akeylink Biotechnology Co., Ltd.
- Target Recruit Count
- 45
- Registration Number
- NCT06263959
- Locations
- 🇨🇳
The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath